Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

ExpreS2ion Biotech Holding

5.09 SEK

+0.79 %

Less than 1K followers

EXPRS2

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ExpreS2ion Biotech Holding

2019202020212022202320242025
Revenue13.815.312.25.17.13.03.7
growth-%10.4 %-19.8 %-58.4 %38.5 %-57.3 %21.5 %
EBITDA-15.2-28.8-46.6-126.4-104.4-104.2-42.8
EBIT-18.1-31.7-48.4-127.6-106.0-67.7-44.3
Profit before taxes-19.1-35.2-47.5-126.6-104.6-44.6-44.2
Net income-16.7-32.0-43.9-118.6-96.0-36.4-38.1
EPS-35.22-62.25-46.56-107.45-71.10-13.70-13.39
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-110.2 %-188.4 %-380.8 %-2,483.1 %-1,480.3 %-3,460.5 %-1,170.4 %
EBIT-%-131.0 %-207.5 %-395.6 %-2,507.1 %-1,503.1 %-2,249.2 %-1,210.6 %
ROE1,548.0 %-33.8 %-31.3 %-114.8 %-157.5 %-56.5 %-106.7 %
ROI-89.3 %-26.9 %-28.9 %-86.3 %-129.3 %-34.8 %-58.5 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.